FDA
approval
· 2020-04-24
FDA Approved: ONGENTYS — Original Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved Ongentys (opicapone) as an add-on therapy to levodopa/carbidopa for adults with Parkinson's disease experiencing motor fluctuations ('off' episodes…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ONGENTYS (OPICAPONE)